SCHEMBL7595

SCHEMBL7595

CCOC(=O)N(c1ccccc1)c1c(C)noc1-c1ccc(-c2ccc(C3(C(=O)OCC)CC3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 8/20 0.44
ABCC3 O15438 1/20 0.44
ABCC4 O15439 1/20 0.44
ABCB11 O95342 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2C9 P11712 1/20 0.44
ABCB4 P21439 1/20 0.44
LPAR1 Q92633 1/20 0.44
ABCC2 Q92887 1/20 0.44
SLCO1B3 Q9NPD5 1/20 0.44
SLCO1B1 Q9Y6L6 1/20 0.44
OPRD1 P41143 6/20 0.43
OPRK1 P41145 6/20 0.43
SLC22A1 O15245 1/20 0.43
SLC6A4 P31645 1/20 0.43
ADRA1A P35348 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2635812 0.97 OPRM1 (0.43) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2635987 0.96 OPRM1 (0.43) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2761373 0.94 OPRM1 (0.41) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6694 0.94 LPAR1 (0.50) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2636832 0.93 LPAR1 (0.47) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2636021 0.92 OPRM1 (0.45) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2635606 0.91 OPRM1 (0.43) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2636702 0.91 CYP2C9 (0.47) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2635977 0.91 ABCC3 (0.38) OPRM1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2635820 0.91 CYP2C9 (0.47) OPRM1ABCC3ABCC4ABCB11CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648726-A1 POLYCYCLIC LPA1 ANTAGONIST AND USES THEREOF Amira Pharmaceuticals, Inc. (US) 2013-10-16 EP disclosed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2012078805-A1 POLYCYCLIC LPA1 ANTAGONIST AND USES THEREOF AMIRA PHARMACEUTICALS, INC. (US) 2012-06-14 WO disclosed
EP-2438048-A2 POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS Amira Pharmaceuticals, Inc. (US) 2012-04-11 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed
WO-2010141768-A2 POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2010-12-09 WO disclosed
WO-2010141761-A2 POLYCYCLIC ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2010-12-09 WO disclosed